The FDA is reviewing a possible link between the asthma drug Xolair and an increased risk of heart and cerebrovascular disorders.Since the FDA investigation is still under way, the agency is not telling doctors to stop prescribing Xolair and is not recommending any changes to the prescribing information for Xolair.
More...
A provision in last year’s One Big Beautiful Bill Act blocked Planned Parenthood’s health centers from...
The U.S. Department of Agriculture confirmed the presence of New World screwworm in a 3-week-old calf...
A smart drug that stops cancer cells “hiding” from treatment can shrink tumours by at least...
